HHS Completes Hantavirus Response Initiative; U.S. Monitoring Concludes with No Confirmed Cases
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
June 24, 2026
By
Assistant Secretary for Public Affairs (ASPA)
June 24, 2026
by Assistant Secretary for Public Affairs (ASPA)
June 24, 2026
The investigational combination pairs islatravir and lenacapavir in a once-weekly single-tablet regimen.
June 10, 2026
Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.
June 3, 2026